![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | THOP1 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Thop1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of THOP1 mRNA | CTD | PMID:36331819 | THOP1 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Thop1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of THOP1 mRNA | CTD | PMID:22206623 | THOP1 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Thop1 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of THOP1 mRNA | CTD | PMID:17555576 and PMID:17942748 | THOP1 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Thop1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of THOP1 mRNA | CTD | PMID:17942748 | THOP1 | Human | 17beta-estradiol | decreases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of THOP1 mRNA | CTD | PMID:32145629 | THOP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Thop1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of THOP1 mRNA | CTD | PMID:17942748 | THOP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Thop1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of THOP1 mRNA | CTD | PMID:21570461 | THOP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of THOP1 mRNA | CTD | PMID:22298810 | THOP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of THOP1 mRNA | CTD | PMID:21215274 and PMID:33387578 | THOP1 | Human | 2,4,6-trinitrotoluene | affects expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | Trinitrotoluene affects the expression of THOP1 mRNA | CTD | PMID:21346803 | THOP1 | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | Thop1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:18550172 | THOP1 | Human | 2,4-dinitrotoluene | affects expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of THOP1 mRNA | CTD | PMID:21346803 | THOP1 | Human | 2,5-hexanedione | increases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | 2 and 5-hexanedione results in increased expression of THOP1 protein | CTD | PMID:15928459 | THOP1 | Human | 2,6-dinitrotoluene | affects expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of THOP1 mRNA | CTD | PMID:21346803 | THOP1 | Human | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:32119087 | THOP1 | Human | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Thop1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of THOP1 mRNA | CTD | PMID:20188158 | THOP1 | Human | 3-chloropropane-1,2-diol | decreases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in decreased expression of THOP1 protein | CTD | PMID:26072098 | THOP1 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of THOP1 mRNA | CTD | PMID:28628672 | THOP1 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of THOP1 protein | CTD | PMID:34186270 | THOP1 | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Thop1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of THOP1 mRNA | CTD | PMID:36041667 | THOP1 | Human | 4-amino-2,6-dinitrotoluene | affects expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of THOP1 mRNA | CTD | PMID:21346803 | THOP1 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of THOP1 intron | CTD | PMID:30157460 | THOP1 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of THOP1 mRNA | CTD | PMID:33167477 | THOP1 | Human | ammonium chloride | affects expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of THOP1 mRNA | CTD | PMID:16483693 | THOP1 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of THOP1 mRNA | CTD | PMID:24449571 | THOP1 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of THOP1 mRNA | CTD | PMID:33212167 | THOP1 | Human | arsenite(3-) | decreases expression | ISO | Thop1 (Mus musculus) | 6480464 | arsenite results in decreased expression of THOP1 protein | CTD | PMID:37955338 | THOP1 | Human | arsenous acid | multiple interactions | EXP | | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to THOP1 protein] | CTD | PMID:26598702 | THOP1 | Human | azathioprine | increases expression | EXP | | 6480464 | Azathioprine results in increased expression of THOP1 mRNA | CTD | PMID:22623647 | THOP1 | Human | benzo[a]pyrene | increases expression | ISO | Thop1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of THOP1 mRNA | CTD | PMID:22228805 | THOP1 | Human | Benzo[k]fluoranthene | decreases expression | ISO | Thop1 (Mus musculus) | 6480464 | benzo(k)fluoranthene results in decreased expression of THOP1 mRNA | CTD | PMID:26377693 | THOP1 | Human | bisphenol A | decreases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of THOP1 mRNA | CTD | PMID:25181051 | THOP1 | Human | bisphenol A | multiple interactions | ISO | Thop1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of THOP1 mRNA | CTD | PMID:36041667 | THOP1 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of THOP1 mRNA | CTD | PMID:33670352 | THOP1 | Human | bisphenol A | increases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of THOP1 mRNA | CTD | PMID:32145629 | THOP1 | Human | Bisphenol B | increases expression | EXP | | 6480464 | bisphenol B results in increased expression of THOP1 protein | CTD | PMID:34186270 | THOP1 | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of THOP1 mRNA | CTD | PMID:28628672 | THOP1 | Human | bisphenol F | multiple interactions | ISO | Thop1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of THOP1 mRNA | CTD | PMID:36041667 | THOP1 | Human | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of THOP1 protein | CTD | PMID:34186270 | THOP1 | Human | bleomycin A2 | decreases expression | ISO | Thop1 (Mus musculus) | 6480464 | Bleomycin results in decreased expression of THOP1 protein | CTD | PMID:29733421 | THOP1 | Human | Brodifacoum | increases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | bromfenacoum results in increased expression of THOP1 protein | CTD | PMID:28903499 | THOP1 | Human | capsaicin | increases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | Capsaicin results in increased expression of THOP1 mRNA | CTD | PMID:16278290 | THOP1 | Human | carbon nanotube | increases expression | ISO | Thop1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | THOP1 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to THOP1 gene] | CTD | PMID:28238834 | THOP1 | Human | chromium(6+) | affects expression | ISO | Thop1 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of THOP1 mRNA | CTD | PMID:28472532 | THOP1 | Human | chromium(6+) | multiple interactions | EXP | | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of THOP1 mRNA | CTD | PMID:38479592 | THOP1 | Human | clofibric acid | multiple interactions | ISO | Thop1 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of THOP1 mRNA | CTD | PMID:17602206 | THOP1 | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of THOP1 mRNA | CTD | PMID:19320972 | THOP1 | Human | cocaine | affects expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | Cocaine affects the expression of THOP1 mRNA | CTD | PMID:20187946 | THOP1 | Human | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of THOP1 mRNA | CTD | PMID:20971185 | THOP1 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of THOP1 mRNA | CTD | PMID:20971185 | THOP1 | Human | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of THOP1 mRNA | CTD | PMID:19167446 | THOP1 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of THOP1 mRNA | CTD | PMID:25562108 | THOP1 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of THOP1 mRNA | CTD | PMID:28628672 | THOP1 | Human | diarsenic trioxide | multiple interactions | EXP | | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to THOP1 protein] | CTD | PMID:26598702 | THOP1 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of THOP1 mRNA | CTD | PMID:37042841 | THOP1 | Human | dibutyl phthalate | decreases expression | ISO | Thop1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of THOP1 mRNA | CTD | PMID:17361019 and PMID:21266533 | THOP1 | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of THOP1 protein | CTD | PMID:23301498 | THOP1 | Human | ethanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of THOP1 mRNA | CTD | PMID:29432896 | THOP1 | Human | fenvalerate | decreases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | fenvalerate results in decreased expression of THOP1 protein | CTD | PMID:33656234 | THOP1 | Human | flutamide | increases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of THOP1 mRNA | CTD | PMID:24136188 | THOP1 | Human | folic acid | decreases expression | ISO | Thop1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of THOP1 mRNA | CTD | PMID:25629700 | THOP1 | Human | hydrogen cyanide | decreases expression | ISO | Thop1 (Mus musculus) | 6480464 | Hydrogen Cyanide results in decreased expression of THOP1 mRNA | CTD | PMID:33914522 | THOP1 | Human | indole-3-methanol | affects expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | indole-3-carbinol affects the expression of THOP1 mRNA | CTD | PMID:21396975 | THOP1 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of THOP1 mRNA | CTD | PMID:28628672 | THOP1 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of THOP1 protein | CTD | PMID:32959892 | THOP1 | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of THOP1 mRNA | CTD | PMID:28903495 | THOP1 | Human | lovastatin | increases expression | ISO | Thop1 (Mus musculus) | 6480464 | Lovastatin results in increased expression of THOP1 mRNA | CTD | PMID:20493250 | THOP1 | Human | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | decreases expression | EXP | | 6480464 | N more ... | CTD | PMID:19013360 | THOP1 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Thop1 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of THOP1 mRNA | CTD | PMID:17602206 | THOP1 | Human | oxaliplatin | multiple interactions | ISO | Thop1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of THOP1 mRNA | CTD | PMID:25729387 | THOP1 | Human | ozone | multiple interactions | ISO | Thop1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of THOP1 mRNA | CTD | PMID:34911549 | THOP1 | Human | paracetamol | affects expression | ISO | Thop1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of THOP1 mRNA | CTD | PMID:17562736 | THOP1 | Human | paracetamol | increases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of THOP1 mRNA | CTD | PMID:33387578 | THOP1 | Human | paraquat | increases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | Paraquat results in increased expression of THOP1 mRNA | CTD | PMID:32680482 | THOP1 | Human | perfluorononanoic acid | decreases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of THOP1 mRNA | CTD | PMID:25812627 | THOP1 | Human | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of THOP1 mRNA | CTD | PMID:25812627 | THOP1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Thop1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of THOP1 mRNA | CTD | PMID:36331819 | THOP1 | Human | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of THOP1 mRNA | CTD | PMID:25812627 and PMID:36326898 | THOP1 | Human | potassium cyanide | increases expression | ISO | Thop1 (Mus musculus) | 6480464 | Potassium Cyanide results in increased expression of THOP1 mRNA | CTD | PMID:33914522 | THOP1 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of THOP1 mRNA | CTD | PMID:34032870 | THOP1 | Human | sodium dichromate | increases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | sodium bichromate results in increased expression of THOP1 mRNA | CTD | PMID:25993096 | THOP1 | Human | thapsigargin | decreases expression | EXP | | 6480464 | Thapsigargin results in decreased expression of THOP1 mRNA | CTD | PMID:22378314 | THOP1 | Human | thioacetamide | increases expression | ISO | Thop1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of THOP1 mRNA | CTD | PMID:23411599 and PMID:34492290 | THOP1 | Human | titanium dioxide | decreases expression | ISO | Thop1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of THOP1 mRNA | CTD | PMID:29264374 | THOP1 | Human | titanium dioxide | decreases methylation | ISO | Thop1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of THOP1 gene and titanium dioxide results in decreased methylation of THOP1 promoter alternative form | CTD | PMID:35295148 | THOP1 | Human | topotecan | multiple interactions | ISO | Thop1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of THOP1 mRNA | CTD | PMID:25729387 | THOP1 | Human | trimellitic anhydride | increases expression | ISO | Thop1 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of THOP1 mRNA | CTD | PMID:19042947 | THOP1 | Human | tunicamycin | decreases expression | EXP | | 6480464 | Tunicamycin results in decreased expression of THOP1 mRNA | CTD | PMID:22378314 | THOP1 | Human | valproic acid | affects expression | ISO | Thop1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of THOP1 mRNA | CTD | PMID:17292431 | THOP1 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of THOP1 gene | CTD | PMID:29154799 | THOP1 | Human | warfarin | increases expression | ISO | Thop1 (Mus musculus) | 6480464 | Warfarin results in increased expression of THOP1 mRNA | CTD | PMID:20493250 | |